logo

For the Inventor, By the Inventor

Englewood Cliffs, NJ, United States of America

Hong Mo Moon

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Dobeel Corporation. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Mo Moon. Retrieved from https://idiyas.com/inventor/hong-mo-moon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Englewood Cliffs, NJ (US) (2006 - 2012)
  • Gyeonggi-do, KR (2012)

Company Filing History:

goldMedal4 out of 4 
 
Dobeel Corporation
 patents

Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents
1. 8216595 - Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant (2012-07-10),
2. 8216589 - HBV vaccine and a process of preparing the same (2012-07-10),
3. 8173599 - Spray-dried collectin compositions and process for preparing the same (2012-05-08),
4. 7135338 - Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism (2006-11-14),

Title: Innovations by Hong Mo Moon

Introduction

Hong Mo Moon is a notable inventor based in Englewood Cliffs, NJ (US). He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on creating effective vaccines that enhance immune responses against various infections.

Latest Patents

Among his latest patents is an HBV vaccine that comprises an entire hepatitis B surface antigen of L protein, M protein, and S protein. This innovative vaccine allows the produced antigens to form virus-like particles, providing various epitopes and excellent immunogenicity. It is designed to induce a strong humoral immune response as well as a cell-mediated immune response. Another significant patent involves a powerful vaccine composition that includes a lipopeptide and poly I:C as an adjuvant. This adjuvant synergistically increases the level of antigen-specific antibody induction and induces a Th1 type immune response, making it highly effective for preventive and therapeutic vaccines against viral or parasitic infections and cancer.

Career Highlights

Hong Mo Moon is currently associated with Dobeel Corporation, where he continues to innovate in the field of vaccine technology. His work has the potential to significantly impact public health by providing more effective vaccination options.

Collaborations

He collaborates with notable colleagues, including Byung Cheol Ahn and Jung Sun Yum, who contribute to his research and development efforts.

Conclusion

Hong Mo Moon's contributions to vaccine innovation highlight his commitment to advancing medical science. His patents reflect a deep understanding of immunology and a dedication to improving health outcomes through effective vaccination strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…